These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3001575)

  • 1. Preparation of rat brain membranes highly enriched with opiate kappa binding sites using site-directed acylating agents: optimization of assay conditions.
    Rothman RB; Bykov V; Danks JA; Jacobson AE; Burke TR; Rice KC; Herkenham M
    Neuropeptides; 1985 Dec; 6(6):503-16. PubMed ID: 3001575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
    Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
    Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
    Tiberi M; Magnan J
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine.
    Morris BJ; Herz A
    Neuroscience; 1986 Nov; 19(3):839-46. PubMed ID: 3025770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic localization of opiate kappa-receptors in the guinea-pig brain.
    Foote RW; Maurer R
    Eur J Pharmacol; 1982 Nov; 85(1):99-103. PubMed ID: 6295776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric model.
    Rothman RB; Bowen WD; Bykov V; Schumacher UK; Pert CB; Jacobson AE; Burke TR; Rice KC
    Neuropeptides; 1984 May; 4(3):201-15. PubMed ID: 6087189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific binding.
    Rothman RB; Danks JA; Jacobson AE; Burke TR; Rice KC; Pert CB
    Neuropeptides; 1984 Jun; 4(4):311-7. PubMed ID: 6206435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma.
    Zhang WM; Jin WQ; Wong TM
    J Mol Cell Cardiol; 1996 Jul; 28(7):1547-54. PubMed ID: 8841942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa opiate receptors localized by autoradiography to deep layers of cerebral cortex: relation to sedative effects.
    Goodman RR; Snyder SH
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5703-7. PubMed ID: 6127675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain.
    Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Kayakiri H; Rothman RB
    Peptides; 1995; 16(6):1083-95. PubMed ID: 8532593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain.
    Pilapil C; Welner S; Magnan J; Gauthier S; Quirion R
    Brain Res Bull; 1987 Nov; 19(5):611-5. PubMed ID: 2825931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine.
    Quirion R; Pilapil C; Magnan J
    Cell Mol Neurobiol; 1987 Sep; 7(3):303-7. PubMed ID: 2830975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brain.
    Petrillo P; La Regina A; Sbacchi M; Tavani A; Robson LE; Kosterlitz HW
    Eur J Pharmacol; 1989 Jul; 166(2):213-7. PubMed ID: 2551699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
    Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.